Cell Source, Inc. – ‘10-K’ for 12/31/21 – ‘EXCEL’

On:  Friday, 4/15/22, at 5:12pm ET   ·   For:  12/31/21   ·   Accession #:  1493152-22-10133   ·   File #:  0-55413

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.93M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     22K 
 3: EX-10.36A   Material Contract                                   HTML     50K 
 4: EX-10.39B   Material Contract                                   HTML     50K 
 5: EX-10.63A   Material Contract                                   HTML     30K 
 6: EX-10.68    Material Contract                                   HTML     53K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
14: R1          Cover                                               HTML     87K 
15: R2          Consolidated Balance Sheets                         HTML    117K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
17: R4          Consolidated Statements of Operations               HTML     78K 
18: R5          Consolidated Statements of Changes in               HTML    167K 
                Stockholders' Deficiency                                         
19: R6          Consolidated Statements of Cash Flows               HTML    165K 
20: R7          Business Organization, Nature of Operations and     HTML     28K 
                Risks and Uncertainties                                          
21: R8          Going Concern and Management?s Plans                HTML     30K 
22: R9          Summary of Significant Accounting Policies          HTML     94K 
23: R10         Fair Value                                          HTML    134K 
24: R11         Accrued Expenses                                    HTML     40K 
25: R12         Accrued Compensation                                HTML     42K 
26: R13         Advances Payable                                    HTML     27K 
27: R14         Notes Payable                                       HTML    222K 
28: R15         Income Taxes                                        HTML     61K 
29: R16         Stockholders? Deficiency                            HTML    241K 
30: R17         Commitments and Contingencies                       HTML     46K 
31: R18         Related Party Transactions                          HTML     28K 
32: R19         Subsequent Events                                   HTML     38K 
33: R20         Summary of Significant Accounting Policies          HTML    128K 
                (Policies)                                                       
34: R21         Summary of Significant Accounting Policies          HTML     42K 
                (Tables)                                                         
35: R22         Fair Value (Tables)                                 HTML    131K 
36: R23         Accrued Expenses (Tables)                           HTML     38K 
37: R24         Accrued Compensation (Tables)                       HTML     41K 
38: R25         Notes Payable (Tables)                              HTML    110K 
39: R26         Income Taxes (Tables)                               HTML     57K 
40: R27         Stockholders? Deficiency (Tables)                   HTML    160K 
41: R28         Going Concern and Management?s Plans (Details       HTML     48K 
                Narrative)                                                       
42: R29         Schedule of Weighted Average Dilutive Common        HTML     35K 
                Shares Anti-dilutive (Details)                                   
43: R30         Schedule of Weighted Average Dilutive Common        HTML     22K 
                Shares Anti-dilutive (Details) (Parenthetical)                   
44: R31         Summary of Significant Accounting Policies          HTML     45K 
                (Details Narrative)                                              
45: R32         Schedule of Changes in Fair Value of Liabilities    HTML     68K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
46: R33         Schedule of Assumptions Used for Valuation of       HTML     40K 
                Level 3 Liabilities (Details)                                    
47: R34         Fair Value (Details Narrative)                      HTML     24K 
48: R35         Schedule of Accrued Expenses (Details)              HTML     36K 
49: R36         Schedule of Accrued Compensation (Details)          HTML     42K 
50: R37         Advances Payable (Details Narrative)                HTML     33K 
51: R38         Schedule of Notes Payable (Details)                 HTML     36K 
52: R39         Schedule of Notes Payable Due to Related Parties    HTML     28K 
                (Details)                                                        
53: R40         Schedule of Convertible Notes Payable (Details)     HTML     39K 
54: R41         Schedule of Convertible Notes Payable (Details)     HTML     34K 
                (Parenthetical)                                                  
55: R42         Schedule of Convertible Notes Payable Due to        HTML     27K 
                Related Parties (Details)                                        
56: R43         Schedule of Convertible Notes Payable Due to        HTML     24K 
                Related Parties (Details) (Parenthetical)                        
57: R44         Notes Payable (Details Narrative)                   HTML    328K 
58: R45         Schedule of Income Before Income Taxes (Details)    HTML     30K 
59: R46         Schedule of Component of Income Tax Expenses        HTML     38K 
                (Benefit) (Details)                                              
60: R47         Schedule of Effective Income Tax Rate               HTML     41K 
                Reconciliation (Details)                                         
61: R48         Schedule of Deferred Tax Assets (Details)           HTML     36K 
62: R49         Income Taxes (Details Narrative)                    HTML     35K 
63: R50         Schedule of Warrant Activity (Details)              HTML     56K 
64: R51         Schedule of Outstanding and Exercisable (Details)   HTML     50K 
65: R52         Schedule of Stock Options Assumption Used           HTML     37K 
                (Details)                                                        
66: R53         Summary of Stock Option Activity (Details)          HTML     54K 
67: R54         Stockholders? Deficiency (Details Narrative)        HTML    281K 
68: R55         Commitments and Contingencies (Details Narrative)   HTML     69K 
69: R56         Related Party Transactions (Details Narrative)      HTML     32K 
70: R57         Subsequent Events (Details Narrative)               HTML     84K 
73: XML         IDEA XML File -- Filing Summary                      XML    129K 
71: XML         XBRL Instance -- form10-k_htm                        XML   2.14M 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX    103K 
10: EX-101.CAL  XBRL Calculations -- clcs-20211231_cal               XML    182K 
11: EX-101.DEF  XBRL Definitions -- clcs-20211231_def                XML    689K 
12: EX-101.LAB  XBRL Labels -- clcs-20211231_lab                     XML   1.37M 
13: EX-101.PRE  XBRL Presentations -- clcs-20211231_pre              XML    966K 
 9: EX-101.SCH  XBRL Schema -- clcs-20211231                         XSD    210K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              397±   546K 
75: ZIP         XBRL Zipped Folder -- 0001493152-22-010133-xbrl      Zip    738K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/08/23  Cell Source, Inc.                 10-K       12/31/22   77:11M                                    M2 Compliance LLC/FA

27 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/21  Cell Source, Inc.                 10-Q        6/30/21   45:7M                                     M2 Compliance LLC/FA
 4/15/21  Cell Source, Inc.                 10-K       12/31/20   71:6.4M                                   Pubco Reporting … Inc/FA
11/13/20  Cell Source, Inc.                 10-Q        9/30/20   50:3.2M                                   Pubco Reporting … Inc/FA
 8/14/20  Cell Source, Inc.                 10-Q        6/30/20   47:2.8M                                   Pubco Reporting … Inc/FA
 5/15/20  Cell Source, Inc.                 10-Q        3/31/20   45:2.1M                                   Pubco Reporting … Inc/FA
 3/30/20  Cell Source, Inc.                 10-K       12/31/19   71:6.1M                                   Pubco Reporting … Inc/FA
 8/14/19  Cell Source, Inc.                 10-Q        6/30/19   49:14M                                    Global Fin’l Corp./FA
 6/19/19  Cell Source, Inc.                 10-K/A     12/31/18    5:245K                                   Global Fin’l Corp./FA
 5/20/19  Cell Source, Inc.                 10-Q        3/31/19   44:2.3M                                   Global Fin’l Corp./FA
 7/25/18  Cell Source, Inc.                 10-K       12/31/17   75:11M                                    Global Fin’l Corp./FA
 8/15/16  Cell Source, Inc.                 10-Q        6/30/16   47:3M                                     Global Fin’l Corp./FA
 5/13/16  Cell Source, Inc.                 10-Q        3/31/16   47:2.6M                                   Global Fin’l Corp./FA
 4/14/16  Cell Source, Inc.                 10-K       12/31/15   66:8.2M                                   Global Fin’l Corp./FA
 7/28/15  Cell Source, Inc.                 8-K:1,3,9   7/20/15    5:235K                                   Global Fin’l Corp./FA
 6/10/15  Cell Source, Inc.                 8-K:1,9     6/04/15    3:57K                                    Toppan Merrill/FA
 6/03/15  Cell Source, Inc.                 8-K:1,2,3,9 5/15/15    4:99K                                    Toppan Merrill/FA
 4/01/15  Cell Source, Inc.                 8-K:2,3,9   3/26/15    3:91K                                    Toppan Merrill/FA
 3/13/15  Cell Source, Inc.                 10-K       12/31/14   60:6.6M                                   Toppan Merrill/FA
12/02/14  Cell Source, Inc.                 8-K:2,9    11/26/14    2:28K                                    Toppan Merrill/FA
 9/23/14  Cell Source, Inc.                 S-1/A                 63:8.1M                                   Toppan Merrill/FA
 8/19/14  Cell Source, Inc.                 10-Q        6/30/14   50:3.1M                                   Toppan Merrill/FA
 8/08/14  Cell Source, Inc.                 S-1                   58:6.2M                                   Toppan Merrill/FA
 7/01/14  Cell Source, Inc.                 8-K:1,2,3,4 6/30/14   16:27M                                    Toppan Merrill/FA
 6/30/14  Cell Source, Inc.                 8-K:1,3,9   6/27/14    3:56K                                    Global Fin’l Corp./FA
 6/26/14  Cell Source, Inc.                 8-K:5,9     6/23/14    2:6K                                     Global Fin’l Corp./FA
 6/06/14  Cell Source, Inc.                 8-K:5,9     5/07/14    2:7K                                     Global Fin’l Corp./FA
 3/05/13  Cell Source, Inc.                 S-1                    7:396K                                   Global Fin’l Corp./FA